3,961
Views
3
CrossRef citations to date
0
Altmetric
Genetic Disease

Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis

, , , &
Pages 783-791 | Received 29 Mar 2022, Accepted 11 May 2022, Published online: 09 Jun 2022